Noticias de SRPT_US

Noticias del mercado

Últimas noticias sobre SRPT_US — 139 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SRPT_US ✕ 139 resultados
22/04/2026 SRPT_US — Law360 ES ← EN
Reserva completa. Circo. Aprueba la oferta de nueva audiencia de patentes de Sarepta
22/04/2026 SRPT_US — MarketBeat ES ← EN
Sarepta Therapeutics, Inc. $ Acciones SRPT compradas por Cwm LLC

Sarepta Therapeutics, Inc. $SRPT Shares Purchased by Cwm LLC

22/04/2026 SRPT_US — Yahoo Finance
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
22/04/2026 SRPT_US — Business Wire
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
22/04/2026 SRPT_US — Law360
Full Fed. Circ. Passes On Sarepta's Patent Rehearing Bid
22/04/2026 SRPT_US — Stock Titan
SRPT Financials: Income Statement, Balance Sheet & Cash Flow
21/04/2026 SRPT_US — MSN ES ← EN
El precio objetivo de Sarepta Therapeutics (SRPT) disminuyó un 10,97% a 22,48
21/04/2026 SRPT_US — MarketBeat
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Hold" from Analysts
20/04/2026 SRPT_US — DirectorsTalk Interviews
Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the Future of RNA-Targeted Therapeutics with Promising Forward P/E
18/04/2026 SRPT_US — Sahm
A Look At Sarepta Therapeutics (SRPT) Valuation After Roche’s New Global Elevidys Phase 3 Trial
17/04/2026 SRPT_US — MSN
Sarepta/ Roche Duchenne therapy to face new late-stage trial targeting EU nod
16/04/2026 SRPT_US — MarketBeat
Sarepta Therapeutics (NASDAQ:SRPT) Shares Pass Above 200 Day Moving Average - Here's Why
16/04/2026 SRPT_US — Seeking Alpha
Sarepta/ Roche Duchenne therapy to face new late-stage trial targeting EU nod
16/04/2026 SRPT_US — Sahm
Will Roche’s New Global Elevidys Phase 3 Trial Shift Sarepta Therapeutics' (SRPT) Gene Therapy Narrative?
15/04/2026 SRPT_US — MSN
Sarepta Therapeutics (SRPT) price target decreased by 10.97% to 22.48
11/04/2026 SRPT_US — MSN
Sarepta Therapeutics (SRPT) price target decreased by 16.58% to 25.25
09/04/2026 SRPT_US — MSN
Sarepta Therapeutics (SRPT) price target decreased by 16.58% to 25.25
08/04/2026 SRPT_US — MarketBeat
Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $19.00 at Royal Bank Of Canada
07/04/2026 SRPT_US — MSN ES ← EN
TD Cowen rebaja la calificación de las acciones de Sarepta Therapeutics (SRPT) para mantenerlas y reduce el PT
07/04/2026 SRPT_US — MarketScreener
RBC Adjusts Price Target on Sarepta Therapeutics to $19 From $18, Maintains Sector Perform Rating

Página 4 de 7

keyboard_arrow_up